Comparison of Procedures for Evaluating Laboratory Performance in External Quality Assessment Schemes for Lead in Blood and Aluminum in Serum Demonstrates the Need for Common Quality Specifications
Author(s) -
Andrew Taylor,
J. Angerer,
F Claeys,
Jesper Kristiansen,
Olav Mazarrasa,
Antonio Menditto,
Marina Patriarca,
Alain Pineau,
Ilse Schoeters,
Christophe Sykes,
Sinikka Valkonen,
Cas Weykamp
Publication year - 2002
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1093/clinchem/48.11.2000
Subject(s) - harmonization , quality (philosophy) , external quality assessment , set (abstract data type) , reliability engineering , computer science , statistics , scheme (mathematics) , quality assurance , lead (geology) , quality management , risk analysis (engineering) , operations management , medicine , mathematics , engineering , mathematical analysis , management system , philosophy , physics , epistemology , acoustics , programming language , geomorphology , geology
BACKGROUNDThe different scoring methods used by eight European External Quality Assessment Schemes (EQASs) for occupational and environmental laboratory medicine were compared to develop suitable quality specifications as a step toward harmonization.METHODSReal results for blood lead and serum aluminum assays, reported by participants in Italian and United Kingdom EQASs, were evaluated according to individual scheme scoring criteria. The same results were then used to produce z scores using scheme-based between-laboratory SDs as the estimate of variability to determine whether simple performance-derived quality specifications produced better agreement among schemes.RESULTSThe schemes gave conflicting assessments of participants' performance, and participants judged to be successful by one scheme could be defined as performing inadequately by another. An approach proposed by Kenny et al. (Scand J Clin Lab Invest 1999;59:585), which uses clinical inputs to set targets for analytical imprecision, bias, and total error allowable, was then used to elaborate quality specifications.CONCLUSIONSWe suggest that the CLIA '88 recommendations for blood lead (+/- 40 micro g/L or +/- 10% of the target concentration, whichever is the greater) could be used as a quality specification, although a revision to +/- 30 micro g/L or +/- 10% is recommended. For serum aluminum, a suitable quality specification of +/- 5 micro g/L or +/- 20% of the target concentration, whichever is the greater, is suggested. These specifications may be used to compare laboratory performance across schemes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom